People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inspiration Biopharmaceuticals Inc | — | Biotechnology | Series D+ | $461.3M | $10.2B | 2009 |
Karen R. Dawes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Karen R. Dawes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lynne R. Rollins | 1 | 3 |
| Michael J. Griffith | 1 | 2 |
| Gordon H. Busenbark | 1 | 2 |
| Scott D. Martin | 1 | 2 |
| John R. Taylor | 1 | 1 |
| Stephen R. Evans-Freke | 1 | 1 |
| Andrew R. Grethlein | 1 | 1 |
| Michael J. Giffith | 1 | 1 |
| Gerard R. Picot | 1 | 1 |
| Barry R. Frankel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.